⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WHWK News
Whitehawk Therapeutics, Inc. Common Stock
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
prnewswire.com
WHWK
Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series
prnewswire.com
WHWK
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026
prnewswire.com
WHWK
Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
prnewswire.com
WHWK
Form 8-K
sec.gov
WHWK
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
prnewswire.com
WHWK
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
prnewswire.com
WHWK
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
prnewswire.com
WHWK
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
prnewswire.com
WHWK
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
prnewswire.com
WHWK